Letter to the Editor: Gabapentin for breakthrough pain due to bone metastases

Abstract

Get full access to this article

View all access options for this article.

References

1 Caraceni A Portenoy RK . a working group of the IASP task force on cancer pain. An international survey of cancer pain characteristics and syndromes. Pain 1999; 82: 263–274.

2 Honore P Mantyh PW . Bone cancer pain: from mechanism to model to therapy. Pain Med 2000; 1: 303–309.

3 Donovan-Rodriguez T Dickenson AH Urch CE . Gabapentin normalizes spinal neuronal responses that correlate with behaviour in a rat model of cancer-induced bone pain. Anesthesiology 2005; 102: 132–140.

4 Caraceni A Zecca E Bonezzi C Arcuri E Yaya Tur R Maltoni M . Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004; 22: 2909–2917.

5 Gilron I Bailey JM Tu D Holden RR Weaver DF Houlden RL . Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324–1334.

6 Eckhardt K Ammon S Hofmann U Riebe A Gugeler N Mikus G . Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000; 91: 185–191.